Production (Stage)
Eastwood Bio-Medical Canada Inc.
EBM.V
TSX
| 01/31/2025 | 10/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 16.14% | -5.38% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 16.14% | -5.38% | |||
| Cost of Revenue | -33.78% | 41.29% | |||
| Gross Profit | 57.83% | -25.84% | |||
| SG&A Expenses | -19.02% | -9.71% | |||
| Depreciation & Amortization | 56.44% | 3.59% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -15.94% | 1.88% | |||
| Operating Income | 67.32% | -16.12% | |||
| Income Before Tax | 74.61% | -35.31% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 74.61% | -35.31% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 74.61% | -35.31% | |||
| EBIT | 67.32% | -16.12% | |||
| EBITDA | 106.93% | -17.24% | |||
| EPS Basic | 76.47% | -41.67% | |||
| Normalized Basic EPS | 70.00% | -25.00% | |||
| EPS Diluted | 76.47% | -41.67% | |||
| Normalized Diluted EPS | 70.00% | -25.00% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||